FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy
FOXO Technologies Inc. , a leader in the field of commercializing epigenetic biomarker technology, today announces it has completed its strategic review, following recent management changes, and...